SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-23-005600
Filing Date
2023-02-28
Accepted
2023-02-28 16:45:03
Documents
5
Effectiveness Date
2023-02-28

Document Format Files

Seq Description Document Type Size
1 S-8 ngm-02x28x2023xsx8.htm S-8 85584
2 EX-5.1 ngm-02x28x2023xs8ex51.htm EX-5.1 11818
3 EX-23.2 ngm-02x28x2023xs8ex232.htm EX-23.2 2649
4 EX-FILING FEES ngm-02x28x2023xs8ex107.htm EX-FILING FEES 23237
5 cooleylogoa.jpg GRAPHIC 9927
  Complete submission text file 0001628280-23-005600.txt   138085
Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Filer) CIK: 0001426332 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270121 | Film No.: 23686431
SIC: 2834 Pharmaceutical Preparations